DK575487A - Praeparat til undgaaelse af sekundaere katarakter - Google Patents
Praeparat til undgaaelse af sekundaere katarakterInfo
- Publication number
- DK575487A DK575487A DK575487A DK575487A DK575487A DK 575487 A DK575487 A DK 575487A DK 575487 A DK575487 A DK 575487A DK 575487 A DK575487 A DK 575487A DK 575487 A DK575487 A DK 575487A
- Authority
- DK
- Denmark
- Prior art keywords
- cytotoxic agent
- preparation
- secondary cataracts
- avoiding secondary
- instilled
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
- A61K47/6827—Ricin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6845—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Lubricants (AREA)
- Liquid Crystal Substances (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92731886A | 1986-11-04 | 1986-11-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK575487D0 DK575487D0 (da) | 1987-11-03 |
| DK575487A true DK575487A (da) | 1988-05-05 |
Family
ID=25454561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK575487A DK575487A (da) | 1986-11-04 | 1987-11-03 | Praeparat til undgaaelse af sekundaere katarakter |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0267005B1 (da) |
| JP (1) | JPH07121878B2 (da) |
| AT (1) | ATE83666T1 (da) |
| AU (1) | AU608257B2 (da) |
| CA (1) | CA1338777C (da) |
| DE (1) | DE3783211T2 (da) |
| DK (1) | DK575487A (da) |
| ES (1) | ES2053561T3 (da) |
| FI (1) | FI95203C (da) |
| GR (1) | GR3007052T3 (da) |
| IE (1) | IE60436B1 (da) |
| NO (1) | NO173974C (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122006000007I1 (de) * | 1987-12-31 | 2006-04-27 | Tanox Biosystems Inc | Antigene epitope, die sich ausschlisslich auf ige-tragenden B-Lymphocyten befinden. |
| WO1995003783A1 (en) * | 1990-03-06 | 1995-02-09 | Houston Biotechnology Incorporated | Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract |
| US5876438A (en) * | 1993-08-02 | 1999-03-02 | Houston Biotechnology Incorporated | Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract |
| US5620013A (en) * | 1994-10-21 | 1997-04-15 | American Cyanamid Company | Method for destroying residual lens epithelial cells |
| US6063116A (en) * | 1994-10-26 | 2000-05-16 | Medarex, Inc. | Modulation of cell proliferation and wound healing |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0044167A3 (en) * | 1980-07-14 | 1982-04-21 | The Regents Of The University Of California | Antibody targeted cytotoxic agent |
| US4432751A (en) * | 1982-03-05 | 1984-02-21 | Baylor College Of Medicine | Monoclonal antibodies against lens epithelial cells and preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
| EP0140109B1 (en) * | 1983-09-15 | 1991-01-23 | The Board Of Trustees Of The Leland Stanford Junior University | Allograft of reduced immunogenicity and method and reagent for making same |
| EP0173648A3 (en) * | 1984-08-30 | 1988-04-27 | Ciba-Geigy Ag | New monoclonal antibodies to glycoconjugates, processes for their production, and applications |
| US4590071A (en) * | 1984-09-25 | 1986-05-20 | Xoma Corporation | Human melanoma specific immunotoxins |
-
1987
- 1987-11-03 FI FI874852A patent/FI95203C/fi not_active IP Right Cessation
- 1987-11-03 EP EP87309722A patent/EP0267005B1/en not_active Expired - Lifetime
- 1987-11-03 DE DE8787309722T patent/DE3783211T2/de not_active Expired - Fee Related
- 1987-11-03 DK DK575487A patent/DK575487A/da not_active Application Discontinuation
- 1987-11-03 NO NO874569A patent/NO173974C/no not_active IP Right Cessation
- 1987-11-03 ES ES87309722T patent/ES2053561T3/es not_active Expired - Lifetime
- 1987-11-03 CA CA000550962A patent/CA1338777C/en not_active Expired - Fee Related
- 1987-11-03 AT AT87309722T patent/ATE83666T1/de not_active IP Right Cessation
- 1987-11-04 AU AU80666/87A patent/AU608257B2/en not_active Ceased
- 1987-11-04 IE IE297787A patent/IE60436B1/en not_active IP Right Cessation
- 1987-11-04 JP JP62279011A patent/JPH07121878B2/ja not_active Expired - Fee Related
-
1993
- 1993-02-11 GR GR930400284T patent/GR3007052T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1338777C (en) | 1996-12-10 |
| NO173974C (no) | 1994-03-02 |
| ATE83666T1 (de) | 1993-01-15 |
| IE872977L (en) | 1988-05-04 |
| DE3783211T2 (de) | 1993-04-29 |
| JPS63211239A (ja) | 1988-09-02 |
| FI95203C (fi) | 1996-01-10 |
| JPH07121878B2 (ja) | 1995-12-25 |
| NO874569L (no) | 1988-05-05 |
| FI95203B (fi) | 1995-09-29 |
| EP0267005A2 (en) | 1988-05-11 |
| NO874569D0 (no) | 1987-11-03 |
| AU608257B2 (en) | 1991-03-28 |
| FI874852A (fi) | 1988-05-05 |
| DK575487D0 (da) | 1987-11-03 |
| DE3783211D1 (de) | 1993-02-04 |
| AU8066687A (en) | 1988-05-05 |
| ES2053561T3 (es) | 1994-08-01 |
| EP0267005A3 (en) | 1989-11-08 |
| FI874852A0 (fi) | 1987-11-03 |
| NO173974B (no) | 1993-11-22 |
| EP0267005B1 (en) | 1992-12-23 |
| IE60436B1 (en) | 1994-07-13 |
| GR3007052T3 (da) | 1993-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2300544A1 (fr) | Lentille intra-oculaire artificielle implantable dans la chambre posterieure de l'oeil | |
| ES8301215A1 (es) | Procedimiento para la preparacion de derivados de aminoaci- dos | |
| ES479206A1 (es) | Un procedimiento para la preparacion de n-heterociclil-4- piperidinamina. | |
| GB615744A (en) | Improvements in or relating to duplicating | |
| IE35642L (en) | Preparation of ó-aminopenicillins | |
| JPS6452722A (en) | Ophthalmic composition | |
| DK575487A (da) | Praeparat til undgaaelse af sekundaere katarakter | |
| SE434739B (sv) | Forfarande enligt patentet 7602406-6 (publ nr 426059) for framstellning av ren druvsyra och meso-vinsyra | |
| AU7039981A (en) | Compositions and methods of lowering intraocular pressure in the hypertensive mammalian eye | |
| DK420979A (da) | Fremgangsmaade til fremstilling af isatinderivater | |
| SE7705812L (sv) | Farmaceutiska ogonberedningar med langsam utsondring, innehallande kollagener samt sett for framstellning derav | |
| KR900702004A (ko) | 수정체 상피세포에 대한 단클론성항체 및 낭외추출후 잔류하는 수정체 상피세포의 증식을 방지하기 위한 방법 | |
| ES472892A1 (es) | Procedimiento para la preparacion de composiciones derivadasde acido 1,3-dioxo-1h-benz(d,e) isoquinolin-3(3h)acetico | |
| ES2085323T3 (es) | Compuestos de espiro-indolin-oxazina con caracteristicas fotocromaticas y fotosensibilizantes y el procedimiento para su preparacion. | |
| DK349579A (da) | Fremgangsmaade til fremstilling af alfaaminophenyleddikesyrederivater | |
| ADLER et al. | PATHOLOGIC STUDY OF OCULAR LESIONS DUE TO LEWISITE (β-CHLOROVINYLDICHLOROARSINE): Changes With and Without BAL (2, 3-Dimercaptopropanol) Therapy | |
| JPS55102516A (en) | Remedy for glaucoma | |
| JPS5592315A (en) | Remedy for cataract | |
| JPS52263A (en) | Process for preparation of 1-alkanesulfonyloxy alkyl-2-alkyl-3-dipheny lmethylenepyrrolidine and its salts | |
| SU670543A1 (ru) | Стекло дл спаивани с металлом | |
| GB1124388A (en) | Reactive monoazo dyes of the benzene-azo-pyrazolone series and process for their manufacture and use | |
| ES485302A1 (es) | Procedimiento para la preparacion de halogenosulfamoilbence-nos | |
| GB950509A (en) | Improvements in or relating to piperazides | |
| GB594337A (en) | Improvements in and relating to folding tables and the like | |
| LEE et al. | Clinical Results of Nd: Yag Laser Posterior Capsulotomy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |